AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A2 and 5-lipoxygenase activities

Hippocampus

Volumn 15, Issue 3, 2005, Pages 370-380

  Ménard, Caroline ^a   Valastro, Barbara ^a   Martel, Marc André ^a   Chartier, Émilie ^a   Marineau, Audrey ^a   Baudry, Michel ^b   Massicotte, Guy ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Arachidonic acid; GluR1; Glutamate receptor; Hippocampus; Lipase

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; BROMOENOL LACTONE; CALCIUM ION; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; LIPOXYGENASE INHIBITOR; MEMBRANE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; SERINE; TRITIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME REGULATION; FROZEN SECTION; HIPPOCAMPUS; INCUBATION TIME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; THAWING;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; BINDING SITES; BINDING, COMPETITIVE; CALCIUM SIGNALING; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; ENZYME INHIBITORS; HIPPOCAMPUS; MALE; NEURONS; PHOSPHOLIPASES A; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; SERINE; SYNAPTIC MEMBRANES; SYNAPTIC TRANSMISSION;

EID: 18744403022     PISSN: 10509631     EISSN: None     Source Type: Journal    
DOI: 10.1002/hipo.20061     Document Type: Article

References (73)

1. Abeliovich A, Chen C, Goda Y, Silva AJ, Stevens CF, Tonegawa S. 1993. Modified hippocampal long-term potentiation in PKCγ-mutant mice. Cell 75:1252-1262.
2. Akers RF, Lovinger DM, Colley PA, Linden DJ, Routtenberg A. 1986. Translocation of protein kinase C activity may mediate hippocampal long-term potentiation. Science 231:587-589.
3. Allison DW, Gelfand VI, Spector I, Craig AM. 1998. Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA vs AMPA receptors. J Neurosci 18:2423-2436.
4. 2. J Biol Chem 272:16069-16072.
5. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR. 1997. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 276:2042-2045.
6. Baudry M, Lynch G. 2001. Remembrance of arguments past: how well is the glutamate receptor hypothesis of LTP holding up after 20 years? Neurobiol Learn Mem 76:284-297.
7. Bettini E, Maggi A. 1991. A rapid method for the quantitation of estrogen receptors in small amounts of tissue. J Immunol Methods 144:87-91.
8. Bi R, Bi X, Baudry M. 1998a. Phosphorylation regulates calpain-mediated truncation of glutamate ionotropic receptors. Brain Res 797:154-158.
9. Bi X, Chen J, Baudry M. 1998b. Calpain-mediated proteolysis of GluR1 subunits in organotypic hippocampal cultures following kainic acid treatment. Brain Res 781:355-357.
10. Bi X, Tocco G, Baudry M. 1994. Calpain-mediated regulation of AMPA receptors in adult rat brain. NeuroReport 6:61-64.
11. Boden SE, Schweizer S, Bertsche T, Dufer M, Drews G, Safayhi H. 2001. Stimulation of leukotriene synthesis in intact polymorphonuclear cells by the 5-lipoxygenase inhibitor 3-oxo-tirucallic acid. Mol Pharmacol 60:267-273.
12. Bredt DS, Nicoll RA. 2003. AMPA receptor trafficking at excitatory synapses. Neuron 40:361-379.
13. Broutman G, Baudry M. 2001. Involvement of the secretory pathway for AMPA receptors in NMDA-induced potentiation in hippocampus. J Neurosci 21:27-34.
14. 2 enzymes in membrane trafficking: mediators of membrane shape and function. Traffic 4:214-221.
15. Burkert E, Szellas D, Radmark O, Steinhilber D, Werz O. 2003. Cell type-dependent activation of 5-lipoxygenase by arachidonic acid. J Leukoc Biol 73:191-200.
16. Capodici C, Pillinger MH, Han G, Philips MR, Weissmann G. 1998. Integrin-dependent homotypic adhesion of neutrophils. Arachidonic acid activates Raf-1/Mek/Erk via a 5-lipoxygenase-dependent pathway. J Clin Invest 102:165-175.
17. 2 in the hippocampus. Hippocampus 8:299-309.
18. Chen W, Glasgow W, Murphy E, Steenbergen C. 1999. Lipoxygenase metabolism of arachidonic acid in ischemic preconditioning and PKC-induced protection in heart. Am J Physiol 276(6 Pt 2):H2094-H2101.
19. Chen YQ, Duniec ZM, Liu B, Hagmann W, Gao X, Shimoji K, Marnett LJ, Johnson CR, Honn KV. 1994. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res 54:1574-1579.
20. Chung HJ, Steinberg JP, Huganir RL, Linden DJ. 2003. Requirement of AMPA receptor GluR2 phosphorylation for cerebellar long-term depression. Science 300:1751-1755.
21. 2 activity is required for Golgi complex and trans Golgi network membrane tubulation. Proc Natl Acad Sci USA 95:8642-8647.
22. 2+/calmodulin kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci USA 96:3269-3274.
23. Dingledine R, Borges K, Bowie D, Traynelis SF. 1999. The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
24. Esteban JA, Shi S-H, Wilson C, Nuriya M, Huganir RL, Malinow R. 2003. PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nat Neurosci 6:136-143.
25. 2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res Bull 49:139-153.
26. 2 inhibitor impairs spatial memory of mice. Jpn J Pharmacol 83:277-278.
27. 2 isoforms in the checkpoint control of acute inflammation. FASEB J 18:489-498.
28. Harder DR, Campbell WB, Roman RJ. 1995. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 32:79-92.
29. Harrison PJ, Law AJ, Eastwood SL. 2003. Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann NY Acad Sci 1003: 94-101.
30. Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, Malinow R. 2000. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 287:2262-2267.
31. 3H]-AMPA binding sites in rat hippocampus. Br J Pharmacol 115:295-301.
32. Huang CC, You JL, Wu MY, Hsu KS. 2004. Rap1-induced p38 mitogen-activated protein kinase activation facilitates AMPA receptor trafficking via the GDI.Rab5 complex. Potential role in (S)-3,5-dihydroxyphenylglycene-induced long term depression. J Biol Chem 279: 12286-12292.
33. Kalyankrishna S, Malik KU. 2003. Norepinephrine-induced stimulation of p38 mitogen-activated protein kinase is mediated by arachidonic acid metabolites generated by activation of cytosolic phospholipase A in vascular smooth muscle cells. J Pharmacol Exp Ther 304:761-772.
34. 2 antagonist, induces dispersal of both Golgi stack- and trans Golgi network-resident proteins throughout the cytoplasm. Biochem Biophys Res Commun 281:582-588.
35. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
36. Lamprecht R, LeDoux J. 2004. Structural plasticity and memory. Nat Rev Neurosci 5:45-54.
37. Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL. 2000. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405:955-959.
38. Lepley RA, Fitzpatrick FA. 1996. Inhibition of mitogen-activated protein kinase kinase blocks activation and redistribution of 5-lipoxygenase in HL-60 cells. Arch Biochim Biophys 331:141-144.
39. Lledo PM, Hjelmstad GO, Mukherji S, Soderling TR, Malenka RC, Nicholl RA. 1995. Calcium/calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism. Proc Natl Acad Sci USA 92:11175-11179.
40. MacIntyre JP, Pope BL. 1991. The involvement of protein kinase C, calcium, and 5-lipoxygenase in the production of tumor necrosis factor by a cloned interleukin-3 dependent cell line with natural cytotoxic activity. Int J Immunopharmacol 13:175-184.
41. Malenka RC. 1994. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78:535-538.
42. Malinow R. 2003. AMPA receptor trafficking and long-term potentiation. Phil Trans R Soc Lond B 358:707-714.
43. 2: its role in adaptive neural plasticity. Cell Mol Life Sci 57: 1542-1550.
44. 2: a necessary step in long-term potentiation? Proc Natl Acad Sci USA 88:1893-1897.
45. 2 in endocytosis. Proc Natl Acad Sci USA 90:10255-10259.
46. Michaelis EK. 1998. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 54:369-415.
47. Mulkey RM, Herron CE, Malenka RC. 1993. An essential role for protein phosphatases in hippocampal long-term depression. Science 261: 1051-1055.
48. Mulkey RM, Endo S, Shenollkar SS, Malenka RC. 1994. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369:486-488.
49. Nayak A, Zastrow DJ, Lickteig R, Zahniser NR, Browning MD. 1998. Maintenance of late-phase is accompanied by PKA-dependent increase in AMPA receptor synthesis. Nature 394:680-683.
50. O'Dell TJ, Kandel ER. 1994. Low-frequency stimulation erases LTP through an NMDA receptor-mediated activation of protein phosphatases. Learn Mem 1:129-139.
51. O'Flaherty JT, Kuroki M, Nixon AB, Wijkander J, Yee E, Lee SL, Smitherman PK, Wykle RL, Daniel LW. 1996. 5-Oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway. J Biol Chem 271: 17821-17828.
52. Papavassiliou AG. 1994. Preservation of protein phosphoryl groups in immunoprecipitation assays. J Immunol Methods 170:67-73.
53. ++ /calmodulin-dependent protein kinase II, cAMP-dependent protein kinase, and casein kinase II. Proc Natl Acad Sci USA 88:6770-6774.
54. 2+/calmodulin-dependent protein kinase II by arachidonic acid and its metabolites. Proc Natl Acad Sci USA 86: 8550-8554.
55. Provost P, Doucet J, Hommarberg T, Gerisch G, Samuelson B, Radmark O. 2001. 5-Lipoxygenase interacts with coactosin-like protein. J Biol Chem 276:16520-16527.
56. Raso E, Tovari J, Toth K, Paku S, Trikha M, Honn KV, Timar J. 2001. Ectopic alphaIIbbeta3 integrin signaling involves 12-lipoxygenase-and PKC-mediated serine phosphorylation events in melanoma cells. Thromb Haemost 85:1037-1042.
57. Ross BM. 2003. Phospholipid and eicosanoid signaling disturbances in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 69:407-412.
58. 2 activity. J Neurochem 70:786-793.
59. 2 activities in brain patients with schizophrenia. Brain Res 821:407-413.
60. Seidenman KJ, Steinberg JP, Huganir RL, Malinow R. 2003. Glutamate receptor subunit 2 serine 880 phosphorylation modulates synaptic transmission and mediates plasticity in CA1 pyramidal cells. J Neurosci 23:9220-9228.
61. Silva AJ, Stevens CF, Tonegawa S, Wang Y. 1992. Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science 257:201-206.
62. Song I, Huganir RL. 2002. Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci 25:578-588.
63. 2 inhibitors selectively increases AMPA receptor-mediated synaptic transmission. Hippocampus 14:319-325.
64. Szekeres CK, Tang K, Trikha M, Honn KV. 2000. Eicosanoid activation of extracellular signal-regulated kinase1/2 in human epidermoid carcinoma cells. J Biol Chem 275:38831-38841.
65. 2 in exocytosis of amylase from parotid acinar cells. J Biochem 121: 1018-1024.
66. 3H-AMPA binding in rat hippocampus. Brain Res 573:228-234.
67. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
68. Valastro, B, Girard M, Gagne JL, Martin F, Parent AT, Baudry M, Massicotte G. 2001. Inositol hexakisphosphate-mediated regulation of glutamate receptors in rat brain sections. Hippocampus 11:673-682.
69. 2+-dependent protein kinase and phosphatase activities controlling synaptic strength. Learn Mem 3:170-181.
70. 2. Implications for cardiac cycle-dependent alterations in phospholipolysis. J Biol Chem 271:20989-20992.
71. 2. FEBS Lett 377:358-362.
72. 2. Anal Biochem 269:278-288.
73. Zhu JJ, Qin Y, Zhao M, Van Aelst L, Malinow R. 2002. Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell 110:443-455.